Mechanisms of disruption of axon transport of autophagic vesicles and lysosomes in C9orf72 ALS
C9orf72 ALS 中自噬囊泡和溶酶体轴突运输破坏的机制
基本信息
- 批准号:10647723
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2023-08-07
- 项目状态:已结题
- 来源:
- 关键词:AffectAmyotrophic Lateral SclerosisAnabolismAutophagocytosisAutophagosomeAxonAxonal TransportBackBindingBiochemicalBiogenesisBiologyC9ALSC9ORF72CellsCytoplasmDataDefectDevelopmentDiseaseDisease modelDistalDrosophila genusEventFoundationsFractionationFrontotemporal DementiaFunctional disorderGenesGeneticGoalsHumanImageImpairmentIn VitroInduced pluripotent stem cell derived neuronsInheritedLabelLaboratoriesLinkLysosomesMembraneMethodsMicrotubulesModelingMotorMotor NeuronsMutationNerve DegenerationNeurodegenerative DisordersNuclear PoreNuclear Pore ComplexOrganellesPathogenesisPathogenicityPathway interactionsPatientsPhenotypePhosphotransferasesPost-Translational Protein ProcessingProcessProteinsRNARegulationTestingTimeTrainingTubulinVesicleWorkcareercareer developmentexperimental studyflygenetic manipulationimaging modalityimprovedin vivoinduced pluripotent stem cellinsightlive cell imagingmotor neuron degenerationneuronal cell bodynucleocytoplasmic transportoverexpressionpharmacologicprotein aggregationproteostasisretrograde transportstress granuletherapeutic evaluationtherapeutic targettooltranscription factortreatment strategy
项目摘要
PROJECT SUMMARY
Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disease characterized by dying-back
degeneration of upper and lower motor neurons. The most common known cause of familial and sporadic
forms of ALS as well as frontotemporal dementia (FTD) is the GGGGCC hexanucleotide repeat expansion
(HRE) in C9ORF72 (C9). Our laboratory and others recently discovered that impaired nucleocytoplasmic
transport (NCT) is a fundamental and early pathogenic event in C9-ALS that requires stress granule formation.
However, downstream effects of impaired NCT are unclear. Recent studies have shown that autophagosome
biosynthesis occurs in the distal axon followed by retrograde transport of autophagic vesicles (AVs) to the
soma as they mature, providing a potential link between axon transport (AT) and autophagy, two mechanisms
well known to be involved early in ALS pathophysiology. In Drosophila expressing 30 GGGGCC repeats
(30R), we have found an accumulation of p62 and lysosomes, suggesting that impaired regulation of
autophagy and lysosomes may be a pathogenic mechanism for C9-ALS. Further, we have found preliminary
evidence of a reduction in retrograde autophagosome transport in 30R Drosophila. Consistent with this,
preliminary experiments in iPS motor neurons (iPSNs) derived from patients with C9-ALS showed an
accumulation of lysosomes in axons. Specific Aim 1 will further characterize axon transport of multiple cargo in
30R Drosophila and C9 iPSNs using live cell imaging methods. Specific Aim 2 will examine the interrelation
between axon transport, autophagy and lysosomal function and determine if rescuing autophagy can rescue
axon transport deficits of AVs. Finally, preliminary fly data shows that Mitf/TFEB, a transcription factor
regulating autophagy and lysosomes, is mislocalized to the cytoplasm in 30R Drosophila, indicating that
impaired nucleocytoplasmic transport may lead to impaired autophagy and lysosome regulation. Specific Aim
3 will address the hypothesis that impaired nucleocytoplasmic transport is upstream of impaired axon transport
defects and disruptions in autophagy. By using powerful parallel approaches in Drosophila, allowing precise
genetic manipulation of AT and autophagy, and iPSNs derived from patients with C9-ALS, allowing
experimental manipulation of human cells with the disease, this proposal will investigate detailed mechanistic
pathways of axon transport and regulation of autophagy and lysosomes in C9-ALS. Results from these studies
will not only aid our understanding of the pathogenesis and treatment strategies of ALS, but they will also
further our understanding of the axonal biology of autophagy, important in all neurodegenerative diseases.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sarah Hatch Berth其他文献
Sarah Hatch Berth的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sarah Hatch Berth', 18)}}的其他基金
Mechanisms of disruption of axon transport of autophagic vesicles and lysosomes in C9orf72 ALS
C9orf72 ALS 中自噬囊泡和溶酶体轴突运输破坏的机制
- 批准号:
10187672 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Mechanisms of disruption of axon transport of autophagic vesicles and lysosomes in C9orf72 ALS
C9orf72 ALS 中自噬囊泡和溶酶体轴突运输破坏的机制
- 批准号:
10435445 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Mechanisms of disruption of axon transport of autophagic vesicles and lysosomes in C9orf72 ALS
C9orf72 ALS 中自噬囊泡和溶酶体轴突运输破坏的机制
- 批准号:
10040769 - 财政年份:2020
- 资助金额:
-- - 项目类别:
相似海外基金
Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
- 批准号:
MR/Y014901/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
- 批准号:
MR/Y014286/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
- 批准号:
MR/Y503502/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
- 批准号:
2317745 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Standard Grant
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
- 批准号:
10759808 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
- 批准号:
10606865 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
- 批准号:
10696512 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
- 批准号:
10848139 - 财政年份:2023
- 资助金额:
-- - 项目类别:
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
- 批准号:
MR/Y001095/1 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Fellowship
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
- 批准号:
488892 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Operating Grants














{{item.name}}会员




